Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:48:50 EST Sat 07 Nov 2026
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.2377+0.001620.7488.2113890.2445  0.2445  0.23510.69  0.21315:58:01Nov 0315 min RT 2¢

Recent Trades - Last 10 of 89
Time ETExPriceChangeVolume
15:58:01Q0.23770.001621,476
15:57:09Q0.23830.002223,000
15:47:21Q0.2370.00092453
15:41:11Q0.2390.0029215,000
15:40:02Q0.2390.0029225,000
15:34:11Q0.239650.003573,045
15:28:42Q0.240.00392400
15:20:27Q0.2390.0029285,000
14:53:03Q0.240.003928,500
14:52:37Q0.240.003926,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-11-03 07:31U:ELTPNews ReleaseElite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq.
2026-08-13 16:12U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information
2026-08-10 16:55U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026
2026-08-04 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
2026-06-29 16:30U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
2026-06-23 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
2026-06-15 07:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
2026-06-01 07:02U:ELTPNews ReleaseElite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
2026-04-02 08:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
2026-02-17 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
2026-02-11 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
2025-11-14 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
2025-11-12 07:02U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R)
2025-11-10 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025